Sign In
Buy CURR
$2.91
-0.0700 (-2.35%)
At Close: Jun 23, 2026
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product de
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
08:15am, Thursday, 11'th Feb 2021
OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, we
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D insufficiency. In response, Se
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
08:30am, Tuesday, 02'nd Feb 2021
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today the
CURE Pharmaceutical's® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
08:15am, Thursday, 29'th Oct 2020
LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging the status quo of the health and wellness sector by bringing i
